This is the report here: Title: The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinsons Disease
Fourth, regarding the microbiota-lipid-depression mediation hypothesis, human intervention data are scarcemost evidence [e.g., (8890) on lipid transformation] comes from germ-free mouse models, but the diversity of the human gut microbiota (e.g., ~1,000 species vs
doi: 10.3390/molecules26020435
10.1097/MOL.0b013e32833854c0 Curr Opin Lipidol
The exact mechanism of modulation of tolerance by GSH is still not entirely known, although Zhu et al
The condition is linked to a range of physical and mental health problems, yet treatment options remain limited